Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
Cuzick J, Sestak I, Forbes JF, Dowsett M, Cawthorn S, Mansel RE, Loibl S, Bonanni B, Evans DG, Howell A; IBIS-II investigators.
Lancet. 2020 Jan 11;395(10218):117-122. doi: 10.1016/S0140-6736(19)32955-1. Epub 2019 Dec 12.
Merkel cell carcinoma, melanoma, metastatic mimics of breast cancer.
Troxell ML.
Semin Diagn Pathol. 2017 Sep;34(5):479-495. doi: 10.1053/j.semdp.2017.05.009. Epub 2017 May 31.
In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
Bosserhoff AK, Moser M, Hein R, Landthaler M, Buettner R.
J Pathol. 1999 Mar;187(4):446-54. doi: 10.1002/(SICI)1096-9896(199903)187:4<446::AID-PATH267>3.0.CO;2-Y.
Quality assessment of a large primary GP skin cancer service in Auckland, New Zealand.
Wen D, Gale K, Martin R.
N Z Med J. 2020 Feb 7;133(1509):17-27.
Immunohistological analysis of P53 expression in human skin tumors.
Urano Y, Oura H, Sakaki A, Nagae H, Matsumoto K, Fukuhara K, Nagae T, Arase S, Ninomiya Y, Nakanishi H, et al.
J Dermatol Sci. 1992 Sep;4(2):69-75. doi: 10.1016/0923-1811(92)90061-f.
In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Oba T, Makino K, Kajihara R, Yokoi T, Araki R, Abe M, Minderman H, Chang AE, Odunsi K, Ito F.
J Immunother Cancer. 2021 May;9(5):e002432. doi: 10.1136/jitc-2021-002432.
Comprehensive Analysis of ETS Family Members in Melanoma by Fluorescence In Situ Hybridization Reveals Recurrent ETV1 Amplification.
Mehra R, Dhanasekaran SM, Palanisamy N, Vats P, Cao X, Kim JH, Kim DS, Johnson T, Fullen DR, Chinnaiyan AM.
Transl Oncol. 2013 Aug 1;6(4):405-12. doi: 10.1593/tlo.13340. Print 2013 Aug.
Heterogeneity in expression of S100 beta mRNA in human melanoma and pleomorphic adenoma demonstrated by in situ hybridization.
Landry CF, Kahn HJ, Baumal R, Marks A, Brown IR.
Am J Pathol. 1991 Nov;139(5):1151-6.
Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM, Hölmich LR, Smith S, Glud M, Andersen KK, Dalton SO, Drzewiecki KT.
JAMA Dermatol. 2015 Oct;151(10):1087-95. doi: 10.1001/jamadermatol.2015.1481.
Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ.
Wassberg C, Thörn M, Yuen J, Hakulinen T, Ringborg U.
Int J Cancer. 1999 Oct 29;83(3):314-7. doi: 10.1002/(sici)1097-0215(19991029)83:3<314::aid-ijc5>3.0.co;2-9.
